HIV AIDS

 
Novavax, J&J Vaccine Candidates Effective Against COVID-19, Variants
January 29, 2021

Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.

FDA Approval Granted for First Long-acting Injectable HIV Therapy
January 25, 2021

Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.

FDA Announced Approval of Second HIV-Prevention Drug
October 04, 2019

The FDA announced October 3 approval of Descovy®, making it the second drug to receive indication for HIV pre-exposure prophylaxis.